Related Experiment Video
Updated: Jun 16, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardiorenal syndrome: still not a defined entity.
Carlo Longhini1, Christian Molino, Fabio Fabbian
1Department of Clinical and Experimental Medicine, University Hospital, St. Anna, Corso Giovecca, 203, 44100, Ferrara, Italy.
Heart failure and kidney disease frequently coexist, worsening outcomes. Managing these cardiorenal patients requires tailored therapies focusing on volume, blood pressure, and renal health to improve survival.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Increasing incidence of heart failure and chronic renal failure due to aging population, interventional cardiology, obesity, and diabetes.
- Coexistence of heart failure and renal failure is frequent, with over half of heart failure patients experiencing renal impairment.
- Renal dysfunction in heart failure patients stems from intrinsic renal disease, hemodynamic issues, or both.
Purpose of the Study:
- To review the complex cardiorenal connection and management strategies for patients with coexisting heart and kidney failure.
- To highlight the multifactorial nature of cardiorenal syndrome beyond simple hemodynamic alterations.
- To emphasize the importance of tailored therapeutic approaches for cardiorenal patients.
Main Methods:
- Review of existing literature on cardiorenal interactions and patient management.
- Discussion of pathophysiological mechanisms including hemodynamic, neurohormonal, inflammatory, and anemia-related factors.
- Emphasis on clinical monitoring and management principles for cardiorenal patients.
Main Results:
- Cardiorenal interactions involve complex mechanisms beyond hemodynamics, including the renin-angiotensin system, oxidative stress, inflammation, anemia, and sympathetic nervous system.
- Renal dysfunction significantly worsens mortality in heart failure patients.
- Effective management requires a holistic approach addressing intravascular volume, blood pressure, renal hemodynamics, and anemia.
Conclusions:
- Management of cardiorenal patients necessitates individualized therapy to maintain patient equilibrium.
- Close monitoring of physical examination, weight, blood pressure, and laboratory values is crucial for early complication detection and prevention.
- Prioritizing management of intravascular volume, blood pressure, renal hemodynamics, and anemia is vital for improving survival in cardiorenal patients.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care